Compare BridgeBio Pharma Inc (BBIO) vs FuelCell Energy Inc (FCEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs FuelCell Energy Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while FuelCell Energy Inc trades at $19.69 (market cap $1.54B). The key difference: BridgeBio Pharma Inc is far larger — about 10.6× FuelCell Energy Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, FuelCell Energy Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | FCEL | |
|---|---|---|
Market Cap | $16.36B | $1.54B |
Sector | Health | Industrials |
52-Week High | $90.17 | $36.01 |
52-Week Low | $47.29 | $3.92 |
Enterprise Value | $18.14B | $1.38B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →
